Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 23.00p 20.00p 26.00p 23.00p 23.00p 23.00p 11,440 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.9 -7.8 -31.9 - 4.32

Genedrive PLC Notice of Results

14/02/2018 7:00am

UK Regulatory (RNS & others)


Genedrive (LSE:GDR)
Historical Stock Chart

1 Year : From Nov 2017 to Nov 2018

Click Here for more Genedrive Charts.

TIDMGDR

RNS Number : 8079E

Genedrive PLC

14 February 2018

For release: 14 February 2018

genedrive plc ("genedrive" or the "Company")

Notice of Interim Results

genedrive plc, (AIM: GDR), the near patient molecular diagnostics company, will be announcing its interim results for the six months ending 31 December 2017 on Tuesday 20 March.

David Budd, Chief Executive Officer, and Matthew Fowler, Chief Financial Officer, will host a presentation and simultaneous live conference call for analysts, followed by a Q&A session, at 9:30am on the day of the results. The presentation will be held at 85 Gresham Street, London, EC2R 7HE.

- Ends -

For further details please contact:

genedrive plc

David Budd: CEO +44 (0)161 989 0245

Matthew Fowler: CFO

Peel Hunt LLP

James Steel +44 (0)207 418 8900

Oliver Jackson

Consilium Strategic Communications

Chris Gardner +44 (0)203 709 5700

Matthew Neal

Laura Thornton

genedrive@consilium-comms.com

Notes to Editors

About genedrive plc

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive(R) platform and MTB/RIF assay has been launched in India and a Genedrive(R) HCV test has received CE-IVD Certification and has been launched in Africa. genedrive has distribution agreements with subsidiaries of Sysmex Corporation for the distribution of the Genedrive(R) platform in the EMEA and Asia Pacific regions.

Further details can be found at: www.genedriveplc.com and www.genedrive.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORTIMMTMBMBMRP

(END) Dow Jones Newswires

February 14, 2018 02:00 ET (07:00 GMT)

1 Year Genedrive Chart

1 Year Genedrive Chart

1 Month Genedrive Chart

1 Month Genedrive Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V:gb D:20181118 02:10:41